5 results
management lupus druginduced sle comparison dil erythematosus hemophagocytic hlh lymphohistiocytosis pmr polymyalgia rheumatica systemic table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
and Management Summary ... 40, F:M 9:1 • Clinical ... Workup: - ANA ... life-threatening • Treatment ... #rheumatology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... life-threatening • Treatment ... comparison #table #rheumatology ... #diagnosis #management
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
accumulation of clinical ... Assessment • Clinical ... immune deficiency, Drugs ... inhibitors under evaluation ... #summary #rheumatology
Polymyalgia Rheumatica (PMR) Diagnosis and Management Summary WHAT? • Polymyalgia rheumatica (PMR) is a common systemic inflammatory
and Management Summary ... • An evaluation ... arthropathies, myositis, malignancy ... based on clinical ... #Management #Rheumatology
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... Workup: - ANA ... cutaneous-DIL • Evolution ... DrugInduced #Lupus #DIL #rheumatology ... #diagnosis #treatment
No results found for "ddxof evaluation aorta aaa em malignancy clinical drugs diagnosis rheumatology treatment summary"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ddxof #evaluation #aorta #aaa #em #malignancy #clinical #drugs #diagnosis #rheumatology #treatment #summary